customer.service@microbix.com 
NEWS RELEASES
Microbix & BioGX Collaborate on real-time PCR Assays & Controls
Quality Controls for Respiratory Viral, Pharyngitis, and Genital Ulcer Disease Panels MISSISSAUGA, CANADA & BIRMINGHAM, ALABAMA,...
Microbix Announces Initiation of Normal Course Issuer Bid
For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 6, 2023 - Microbix Biosystems Inc. (TSX:...
Microbix Presenting at Florida Capital Event Conference
Meetings with Growth-Oriented Investors, November 17 to 19, 2023 MISSISSAUGA, CANADA, November 17, 2023 - Microbix Biosystems Inc. (TSX:...
Microbix Clot-Buster Drug Fully-Funded For Return to U.S. Market
Sequel Pharma Reconfirms Kinlytic® urokinase Support for Catheter Clearance Indication MISSISSAUGA, CANADA, November 16, 2023 – Microbix...
Microbix & Ulisse Biomed Collaborate on HPV Controls & Assays
Onboarding Tools and Quality Controls for Extended Genotype HPV Assays MISSISSAUGA, CANADA & TRIESTE, ITALY, November 10, 2023 –...
Microbix QAPs Supporting HPV Testing in Ireland
Distribution Partner Secures Contract Relating to Cervical Cancer Screening MISSISSAUGA, CANADA, October 27, 2023 – Microbix Biosystems...
Microbix Presenting at Muskoka Capital Conference
Meetings with Growth-Oriented Investors, September 29 to October 1, 2023 MISSISSAUGA, CANADA, September 29, 2023 - Microbix Biosystems...
Microbix Achieves New QAPs Sales Record
Over C$ 1 Million in Orders from Leading Diagnostics Industry Test-Maker MISSISSAUGA, CANADA, September 27, 2023 – Microbix Biosystems...
Microbix Honours the Passing of its Founder William J. Gastle – 1948 to 2023
Microbix Honours the Passing of its Founder William J. Gastle – 1948 to 2023 MISSISSAUGA, CANADA, September 13, 2023 – Microbix Biosystems...
Microbix Reports Results for Q3 Fiscal 2023
Strong Sales of $5.5 million alongside Drug Partnering Agreement MISSISSAUGA, August 10, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Microbix Successfully Upgrades Logistics Software Systems
Achieves “Go-Live” with New ERP and eQMS Solutions MISSISSAUGA, CANADA, August 4, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,...
Microbix Presents Results of STI Test Controls at AACC
FLOQSwab-formatted QAPs Supporting Fourplex PCR Tests for Bacterial STIs MISSISSAUGA, CANADA, July 24, 2023 – Microbix Biosystems Inc....
